Asperuloside Improves Obesity and Type 2 Diabetes through Modulation of Gut Microbiota and Metabolic Signaling

Anna Nakamura, Yoko Yokoyama, Kazuki Tanaka, Giorgia Benegiamo, Akiyoshi Hirayama, Qi Zhu, Naho Kitamura, Taichi Sugizaki, Kohkichi Morimoto, Hiroshi Itoh, Shinji Fukuda, Johan Auwerx, Kazuo Tsubota, Mitsuhiro Watanabe

Research output: Contribution to journalArticlepeer-review

Abstract

Human Metabolism; Microbiome

Original languageEnglish
Article number101522
JournaliScience
Volume23
Issue number9
DOIs
Publication statusPublished - 2020 Sep 25

Keywords

  • Human Metabolism
  • Microbiome

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Asperuloside Improves Obesity and Type 2 Diabetes through Modulation of Gut Microbiota and Metabolic Signaling'. Together they form a unique fingerprint.

Cite this